Comparing a new 3D-printed leg brace with standard surgery for treating shin bone fractures

ISRCTN ISRCTN10781625
DOI https://doi.org/10.1186/ISRCTN10781625
Sponsor Luoyang Orthopedic Hospital of Henan Province (Henan Provincial Orthopedic Hospital)
Funder Luoyang Orthopedic Hospital of Henan Province (Henan Provincial Orthopedic Hospital)
Submission date
21/05/2026
Registration date
28/05/2026
Last edited
21/05/2026
Recruitment status
No longer recruiting
Overall study status
Ongoing
Condition category
Musculoskeletal Diseases
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Mr Xiaohui Teng
Principal investigator, Scientific, Public

Luoyang Orthopedic Hospital of Henan Province (Henan Provincial Orthopedic Hospital),No. 82 Qiming South Road
Luoyang
471000
China

Phone +86 17596534816
Email 17596534816@163.com

Study information

Primary study designInterventional
AllocationRandomized controlled trial
MaskingOpen (masking not used)
ControlActive
AssignmentParallel
PurposeTreatment
Scientific titleClinical efficacy of digital intelligence-based 3D-printed reduction braces in the treatment of tibiofibular fractures
Study objectives
Ethics approval(s)

Approved 09/05/2026, Ethics Committee of Henan Luoyang Orthopedic Hospital (Henan Provincial Orthopedic Hospital) (Luoyang Orthopedic Hospital of Henan Province (Henan Provincial Orthopedic Hospital),No. 82 Qiming South Road, Luoyang, Luoyang, 471000, China; +86 379-63546181; hnslyzgyyllwyh@aliyun.com), ref: 2026YJSKT0022-02

Health condition(s) or problem(s) studiedTibiofibular fractures (closed tibial shaft fractures)
InterventionParticipants were randomly assigned to either the intervention group or the control group.
The intervention group received treatment utilizing a patient-specific, digital intelligence-based, 3D-printed reduction brace, which was combined with closed reduction and percutaneous fixation. Preoperative CT data were employed for three-dimensional reconstruction, virtual reduction simulation, and the design of individualized braces. During the surgical procedure, the customized 3D-printed brace was applied to guide fracture reduction and facilitate Kirschner wire fixation through pre-designed channels.
The control group underwent conventional suprapatellar intramedullary nail fixation under fluoroscopic guidance.
Both groups received standardized postoperative nursing care, including anticoagulation therapy, infection prophylaxis, and rehabilitation training, according to the same postoperative protocol.
There is no follow up.
Intervention typeDevice
PhaseNot Applicable
Drug / device / biological / vaccine name(s)Digital intelligence-based 3D-printed reduction brace
Primary outcome measure(s)
  1. Operative time measured using Minutes measured from skin incision to wound closure using operating room record at At the end of surgery
  2. Intraoperative fluoroscopy frequency measured using Number of times C-arm fluoroscopy is used during the operation (recorded by operating room staff) at During surgery
  3. Intraoperative blood loss measured using Estimated blood loss in milliliters (mL) using suction canister measurement and weighing of surgical gauze/swabs at During surgery
Key secondary outcome measure(s)
Completion date01/09/2027

Eligibility

Participant type(s)
Age groupMixed
Lower age limit12 Years
Upper age limit65 Years
SexAll
Target sample size at registration30
Total final enrolment28
Key inclusion criteria1. Age between 12 and 65 years, irrespective of gender
2. AO/OTA 42 type tibial shaft fractures, with or without associated fibular fractures (4F2)
3. Absence of other concomitant injuries or congenital diseases that could interfere with fracture healing
4. Signed informed consent and the ability to cooperate fully with the entire treatment process and subsequent follow-up
Key exclusion criteria1. Open, neglected, or pathological fractures
2. Bilateral tibiofibular fractures
3. Pregnant or lactating women
4. Patients with severe cardiovascular disease, hepatic or renal dysfunction, severe coagulopathy, or other critical illnesses that preclude surgical tolerance
5. Patients with major psychiatric disorders
Date of first enrolment01/09/2025
Date of final enrolment01/02/2026

Locations

Countries of recruitment

  • China

Study participating centres

Results and Publications

Individual participant data (IPD) Intention to shareNo

Editorial Notes

21/05/2026: Trial's existence confirmed by Ethics Committee of Henan Luoyang Orthopedic Hospital (Henan Provincial Orthopedic Hospital).